Planta Med 2011; 77(3): 248-251
DOI: 10.1055/s-0030-1250285
Biological and Pharmacological Activity
Original Papers
© Georg Thieme Verlag KG Stuttgart · New York

Hypopigmenting Activity of Bisabolangelone Isolated from Angelica koreana Maxim. in α-Melanocyte Stimulating Hormone-Activated B16 or Melan-a Cells

Eunmiri Roh1 , Cheong-Yong Yun1 , Jin Woo Lee1 , Chul Lee1 , Bang Yeon Hwang1 , Sun Tack Oh2 , Sang-Hun Jung3 , Sang-Bae Han1 , Youngsoo Kim1
  • 1College of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea
  • 2R & D Department, Cosmecca Korea Co., Chungbuk, Republic of Korea
  • 3College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea
Further Information

Publication History

received January 14, 2010 revised July 25, 2010

accepted July 27, 2010

Publication Date:
02 September 2010 (online)

Abstract

Tyrosinase is a key enzyme in the biosynthetic pathway of melanin pigments. Abnormal accumulation of melanin pigments causes melasma, freckles, and senile lentigo, which can be substantially ameliorated by treatment with arbutin or other tyrosinase inhibitors. In this study, roots of Angelica koreana Maxim. (Umbelliferae) inhibited melanin production in α-melanocyte stimulating hormone (α-MSH)-activated B16 melanoma cells or melan-a melanocytes. To elucidate the hypopigmenting principle of A. koreana, the plant extracts were subjected to bioassay-guided phytochemical analysis, resulting in the identification of bisabolangelone. Bisabolangelone dose-dependently inhibited α-MSH-induced melanin production in B16 or melan-a cells with IC50 values of 9–17 µM. The positive control arbutin also inhibited melanin production in B16 cells with an IC50 value of 317 µM. Bisabolangelone suppressed α-MSH-inducible protein levels of tyrosinase in B16 cells but could not significantly inhibit the catalytic activity of cell-free tyrosinase. Taken together, this study indicates that bisabolangelone is the primary hypopigmenting principle of A. koreana and may have pharmacological potential in the melanin-associated hyperpigmentation disorders.

References

  • 1 Slominski A, Tobin D J, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation.  Physiol Rev. 2004;  84 1155-1228
  • 2 Hearing V J, Tsukamoto K. Enzymatic control of pigmentation in mammals.  FASEB J. 1991;  5 2902-2909
  • 3 Le Pape E, Wakamatsu K, Ito S, Wolber R, Hearing V J. Regulation of eumelanin/pheomelanin synthesis and visible pigmentation in melanocytes by ligands of the melanocortin 1 receptor.  Pigment Cell Melanoma Res. 2008;  21 477-486
  • 4 Busca R, Ballotti R. Cyclic AMP: a key messenger in the regulation of skin pigmentation.  Pigment Cell Res. 2000;  13 60-69
  • 5 Solano F, Briganti S, Picardo M, Ghanem G. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects.  Pigment Cell Res. 2006;  19 550-571
  • 6 Kim Y M, Yun J, Lee C K, Lee H, Min K R, Kim Y. Oxyresveratrol and hydroxystilbene compounds: inhibitory effect on tyrosinase and mechanism of action.  J Biol Chem. 2002;  277 16340-16344
  • 7 Kim K S, Kim J A, Eom S Y, Lee S H, Min K R, Kim Y. Inhibitory effect of piperlonguminine on melanin production in melanoma B16 cell line by down-regulation of tyrosinase expression.  Pigment Cell Res. 2006;  19 90-98
  • 8 Yun C Y, Kim D, Lee W H, Park Y M, Lee S H, Na M, Jahng Y, Hwang B Y, Lee M K, Han S B, Kim Y. Torilin from Torilis japonica inhibits melanin production in α-melanocyte stimulating hormone-activated B16 melanoma cells.  Planta Med. 2009;  75 1505-1508
  • 9 Kang S W, Kim H K, Lee W J, Ahn Y J. Toxicity of bisabolangelone from Ostericum koreanum roots to Dermatophagoides farinae and Dermatophagoides pteronyssinus.  J Agric Food Chem. 2006;  54 3547-3550
  • 10 Seo E K, Kim K H, Kim M K, Cho M H, Choi E, Kim K, Mar W. Inhibitors of 5α-reductase type I in LNCaP cells from the roots of Angelica koreana.  Planta Med. 2002;  68 162-163
  • 11 Jung H W, Mahesh R, Park J H, Boo Y C, Park K M, Park Y K. Bisabolangelone isolated from Ostericum koreanum inhibits the production of inflammatory mediators by down-regulation of NF-κB and ERK MAP kinase activity in LPS-stimulated RAW 264.7 cells.  Int Immunopharmacol. 2010;  10 155-162
  • 12 Wang J, Zhu L, Zou K, Cheng F, Dan F, Guo Z, Cai Z, Yang J. The anti-ulcer activities of bisabolangelone from Angelica polymorpha.  J Ethnopharmacol. 2009;  123 343-346
  • 13 Maeda K, Fukuda M. Arbutin: mechanism of its depigmenting action in human melanocyte culture.  J Pharmacol Exp Ther. 1996;  276 765-769
  • 14 Chang Y H, Kim C, Jung M, Lim Y H, Lee S, Kang S. Inhibition of melanogenesis by selina-4(14),7(11)-dien-8-one isolated from Atractylodis Rhizoma Alba.  Biol Pharm Bull. 2007;  30 719-723
  • 15 Choi J Y, Choi E H, Jung H W, Oh J S, Lee W H, Lee J G, Son J K, Kim Y, Lee S H. Melanogenesis inhibitory compounds from Saussureae Radix.  Arch Pharm Res. 2008;  31 294-299
  • 16 Ohguchi K, Ito M, Yokoyama K, Iinuma M, Itoh T, Nozawa Y, Akao Y. Effects of sesquiterpene lactones on melanogenesis in mouse B16 melanoma cells.  Biol Pharm Bull. 2009;  32 308-310
  • 17 Ao Y, Park H Y, Olaizola-Horn S, Gilchrest B A. Activation of cAMP-dependent protein kinase is required for optimal α-melanocyte-stimulating hormone-induced pigmentation.  Exp Cell Res. 1998;  244 117-124
  • 18 Shibahara S, Yasumoto K, Amae S, Udono T, Watanabe K, Saito H, Takeda K. Regulation of pigment cell-specific gene expression by MITF.  Pigment Cell Res. 2000;  8 98-102

Prof. Youngsoo Kim, Ph.D.

College of Pharmacy
Chungbuk National University

Gaeshin-dong 12

Cheongju 361-763

Republic of Korea

Phone: +82 4 32 61 28 23

Fax: +82 4 32 68 27 32

Email: youngsoo@chungbuk.ac.kr

>